BioSpace News Archive

Epic Sciences (Epic), the maker of the world’s first predictive test of drug response in prostate cancer, announced the expansion of its leadership team with the appointment of Katherine Atkinson as chief commercial officer.

Ampersand Capital Partners, together with the management team of NEOMED-LABS and the NEOMED Institute, announced today that Ampersand has partnered with management in the acquisition of NEOMED-LABS from its not-for-profit founder and parent, the NEOMED Institute.

Boulder Crest, a pioneering nonprofit focused on facilitating Posttraumatic Growth is launching the Boulder Crest Institute on Sept. 12, 2018.

Chinese online B2C pharmacy and healthcare services platform Jianke today announced that it has successfully closed a USD130 million Series B financing round, led by GTJA Investment Group, with participation from HBM Healthcare Investments and Crescent Point.

The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for esketamine nasal spray.

Sickle Cell disease is a condition that affects people around the world. In Georgia there are more than 7,000 people living with Sickle Cell.

Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that management will present at the Morgan Stanley Global Healthcare Conference on Thursday, September 13, 2018 at 2:05 p.m. EDT. The presentation will be webcast live and available for replay from Seattle Genetics’ website at www.seattlegenetics.com in the Investors section.

In its continuing commitment to improve access to affordable health care for all Americans, CVS Health [NYSE: CVS] is kicking off its annual Project Health campaign at CVS Pharmacy locations in the greater Los Angeles area this Thursday, September 6, with free health and wellness screenings

In its continuing commitment to improve access to affordable health care for all Americans, CVS Health [NYSE: CVS] is kicking off its annual Project Health campaign at CVS Pharmacy locations in the New York City area this Thursday, September 6, with free health and wellness screenings.

In its continuing commitment to improve access to affordable health care for all Americans, CVS Health [NYSE: CVS] is kicking off its annual Project Health campaign at CVS Pharmacy locations in the Washington, D.C. area this Thursday, September 6, with free health and wellness screenings.